Related News

Earlier Ovary Removal Provides Greatest BRCA-Associated Benefit

Feb 26, 2014

In particular, women with BRCA1 mutation should have surgery by age 35, researchers say


ASCO: Pazopanib Ups Survival in Advanced Ovarian Cancer

Jun 4, 2013

Maintenance therapy linked to longer progression-free survival after surgery for advanced disease


Strict Ovarian CA Screening Adherence Called for in High-Risk

Dec 6, 2012

In high-risk patients, even with annual screening, incident cancers are rarely early-stage